Literature DB >> 14757139

Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat.

Alessandra Ottani1, Anna Valeria Vergoni, Sabrina Saltini, Chiara Mioni, Daniela Giuliani, Marta Bartiromo, Davide Zaffe, Annibale R Botticelli, Anna Ferrari, Alfio Bertolini, Susanna Genedani.   

Abstract

It has been previously described that gamma-hydroxybutyrate (GHB) provides significant protection against transient global cerebral ischemia in the rat (four vessel occlusion model), when given 30 min before or 10 min after artery occlusion. Here, we show that in the same rat model, significant protection can also be obtained when treatment is started 2 h after the ischemic episode. In saline-treated animals, 30 min of global ischemia followed by reperfusion caused a massive loss of neurons in the hippocampal CA1 subfield (examined 63 days after the ischemic episode), and an impairment of sensory-motor performance (tested on the 51st and 63rd days after ischemia) and of spatial learning and memory (evaluated starting 46 days after the ischemic episode). Treatment with GHB--300 mg/kg intraperitoneally (i.p.) 2 h after the ischemia-reperfusion episode, followed by 100 mg/kg i.p. twice daily for the following 10 days--afforded a highly significant protection, against both histological damage and sensory-motor and learning-memory impairments. These data further suggest the possible therapeutic effectiveness of GHB in brain ischemia, and indicate that the underlying mechanism of action involves non-immediate steps of the ischemia-induced cascade of events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757139     DOI: 10.1016/j.ejphar.2003.11.072

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  The Continued Promise of Neuroprotection for Acute Stroke Treatment.

Authors:  Shimin Liu; Steven R Levine
Journal:  J Exp Stroke Transl Med       Date:  2008

2.  Learning and memory impairment induced by 1,4-butanediol is regulated by ERK1/2-CREB-BDNF signaling pathways in PC12 cells.

Authors:  Congying Chen; Lingling Bu; Huan Liu; Yifeng Rang; Huiying Huang; Xueman Xiao; Genghua Ou; Chunhong Liu
Journal:  Metab Brain Dis       Date:  2022-03-29       Impact factor: 3.655

3.  Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via neuroprotection associated with anti-apoptotic activity.

Authors:  Juan Bin; Qian Wang; Ye-Ye Zhuo; Jiang-Ping Xu; Han-Ting Zhang
Journal:  Metab Brain Dis       Date:  2012-07-29       Impact factor: 3.584

4.  Neuroprotective effects of the new Na channel blocker rs100642 in global ischemic brain injury.

Authors:  Suat Kamisli; Cenk Basaran; Kadir Batcioglu; Mustafa Namık Oztanir; Mehmet Gul; Basri Satilmis; Ayse Burcin Uyumlu; Basak Kayhan; Metin Genc
Journal:  Arch Med Sci       Date:  2019-03-04       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.